Construction and immunogenicity of DNA vaccine of Ag85A gene of mycobacterium tuberculosis

Journal of Xi'an Jiaotong University (Medical Sciences)

Volumn 24, Issue 5, 2003, Pages 416-419

  Chen, Haiwen ^a   Wang, Ziming ^a   Fan, Xionglin ^a   Shi, Tao ^a   Qin, Zhaoyin ^a   He, Dalin ^a   Li, Yuan ^a   Xu, Zhikai ^a  

^a THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Ag85A; DNA vaccine; Mycobacterium tuberculosis

Indexed keywords

BACTERIAL DNA; DNA VACCINE; RESTRICTION ENDONUCLEASE;

ANTIBODY TITER; BACTERIAL GENE; BACTERIAL STRAIN; CLONING VECTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; GENETIC CODE; MOLECULAR CLONING; POLYMERASE CHAIN REACTION;

EID: 0242625935     PISSN: 16718259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Baldwin SL, D'Souza C, Roberts AD, et al. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis [J]. Infect Immun, 1998, 66(6):2951-2959.
2. Rishmann P, Desgrandchamps F, Malavaud B, et al. BCG intravesical instillations: recommendations for side-effects management [J]. Eur Urol, 2000, 37(suppl 1): 33-36.
3. Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo [J]. Science, 1990, 247 (4949 Pt 1): 1465-1468.
4. Tanghe A, Content J, Van Vooren JP, et al. Protective efficacy of a DNA vaccine encoding antigen 85A from mycobacterium bovis BCG against buruli ulcer [J]. Infect Immun, 2001, 69 (9): 5403-5411.
5. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual [M]. 2nd. New York: Cold Spring Harbor Laboratory Press, 1992, 16-69.
6. Zlotta AR, Van Vooren JP,Denis O, et al. What are the immunologically active components of bacilli Calmette-Guérin in therapy of superficial bladder cancer [J]. Int J Cancer, 2000, 87 (6):844-852.
7. Zlotta AR, Drowar A, Van Vooren JP, et al. Superficial bladder tumors and increased reactivity against myobacterial antigens before bacillus Calmette-Guerin therapy [J]. J Urol. 1998, 159(6):1885-1891.
8. Gomella LG, Masterangelo MJ, McCue PA, et al. Phase I study of intravesical vacciniavirus as a vector for gene therapy of bladder cancer [J]. J Urol, 2001, 166(4):1291-1295.